ADMA Biologics, Inc. (ADMA)
17.31
-0.19
(-1.09%)
USD |
NASDAQ |
Jan 16, 16:00
17.40
+0.09
(+0.52%)
After-Hours: 20:00
ADMA Biologics Shareholders Equity (Annual): 349.02M for Dec. 31, 2024
Shareholders Equity (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Annual) Benchmarks
| Arcutis Biotherapeutics, Inc. | 157.54M |
| Vanda Pharmaceuticals, Inc. | 538.55M |
| Aldeyra Therapeutics, Inc. | 71.00M |
| Marker Therapeutics, Inc. | 18.56M |
| CorMedix, Inc. | 84.66M |